dr. morgan on olaparib for metastatic castration-resistant prostate cancer
Published 6 years ago • 964 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
1:00
dr. morgan discusses the impact of parp inhibitors in prostate cancer
-
0:52
dr. morgan on combinations with parp inhibitors in prostate cancer
-
1:32
dr. morgan on enrolling patients with prostate cancer onto clinical trials
-
3:48
olaparib zytiga for metastatic castrate-resistant prostate cancer | learn about clinical trials
-
0:47
dr. morgan on the role of parp inhibitors in prostate cancer
-
2:59
niraparib and abiraterone acetate for metastatic castration-resistant prostate cancer
-
4:30
profound: olaparib for hrr mcrpc
-
1:14
dr. yu on combining pembrolizumab and olaparib in mcrpc
-
16:20
olaparib for metastatic castration-resistant prostate cancer
-
4:55
parp inhibitors in castrate-resistant prostate cancer
-
15:43
olaparib for metastatic castration resistant prostate cancer
-
1:45
the propel clinical trial exploring olaparib plus abiraterone in mcrpc
-
1:30
dr. agarwal on the safety profile of olaparib in hrr gene-mutant mcrpc
-
1:31
dr. higano discusses parp inhibitors in prostate cancer
-
6:16
evolution of treatment for metastatic castration-resistant prostate cancer
-
8:45
clinical trials in nonmetastatic castration-resistant prostate cancer
-
3:07
propel: olaparib plus abiraterone as 1l treatment for metastatic crpc
-
1:19
nov202 increases olaparib efficacy in prostate cancer xenografts
-
1:35
parp inhibitors for the treatment of metastic castration-resistant prostate cancer